Form 4: Anika Therapeutics EVP David Colleran Reports Stock Transactions
SEC Form 4 Filing
David Colleran, EVP, General Counsel, and Corporate Secretary of Anika Therapeutics, reports the vesting of RSUs and associated stock transactions.
Summary
- On March 10, 2025, David Colleran, EVP, General Counsel, and Corporate Secretary of Anika Therapeutics, reported transactions involving Anika Therapeutics common stock.
- These transactions included the vesting of 5,465 Restricted Stock Units (RSUs) and the subsequent withholding of 1,604 shares to cover tax obligations.
- Colleran also acquired shares through the Employee Stock Purchase Plan.
- Following these transactions, Colleran directly owns 37,986 shares of Anika Therapeutics common stock.
Sentiment
Score: 6
Explanation: Neutral sentiment as it reflects routine executive compensation and stock transactions. No clear positive or negative implications for the company's performance.
Positives
- The vesting of RSUs indicates a form of compensation and alignment of interests between the executive and the company's performance.
Future Outlook
The RSUs vest in three equal annual installments beginning March 9, 2024, suggesting future similar filings.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency to investors regarding management's stake in the company.
Stakeholder Impact
- Shareholders gain insight into executive compensation and ownership structure.
- Employees participating in the Employee Stock Purchase Plan are able to acquire company stock.
Key Dates
| Date | Description |
|---|---|
| March 9, 2023 | Date of grant for the RSUs, vesting in three equal annual installments. |
| May 14, 2024 | Colleran purchased 800 shares through the Employee Stock Purchase Plan. |
| November 14, 2024 | Colleran purchased 330 shares through the Employee Stock Purchase Plan. |
| March 7, 2025 | Trading day prior to RSU vesting, ANIK closing price was $16.62. |
| March 9, 2025 | Second vesting installment of RSUs granted on March 9, 2023. |
| March 10, 2025 | Date of reported transactions: RSU vesting and tax withholding. |
| March 11, 2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.